11.69

1.82% 0.202

Roivant Sciences Ltd (ROIV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ROIV? Forum Prognose

Schlusskurs vom Vortag:

$11.49

Offen:

$11.65

24-Stunden-Volumen:

683.58K

Relative Volume:

0.12

Marktkapitalisierung:

$8.28B

Einnahmen:

$158.30M

Nettoeinkommen (Verlust:

$4.74B

KGV:

-8.7254

EPS:

-1.34

Netto-Cashflow:

$-710.11M

1W Leistung:

+0.50%

1M Leistung:

+0.68%

6M Leistung:

+4.17%

1J Leistung:

+35.40%

1-Tages-Spanne:

$11.62

$11.82

1-Wochen-Bereich:

$11.04

$11.82

52-Wochen-Spanne:

$8.611

$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Firmenname

Roivant Sciences Ltd

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

441-295-5950

Adresse

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11

Mitarbeiter

908

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

ROIV's Discussions on Twitter

Vergleichen Sie ROIV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ROIV	11.69	8.28B	158.30M	4.74B	-710.11M	-1.34
VRTX	446.95	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	742.11	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	588.63	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	250.00	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.98	24.49B	3.30B	-501.07M	1.03B	11.54

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-15	Eingeleitet	Wolfe Research	Outperform
2024-01-05	Eingeleitet	Piper Sandler	Overweight
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-10-17	Eingeleitet	Guggenheim	Buy
2023-06-08	Eingeleitet	BofA Securities	Neutral
2022-10-27	Eingeleitet	JP Morgan	Overweight
2022-05-23	Eingeleitet	SVB Leerink	Outperform
2022-04-29	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-15	Eingeleitet	Goldman	Buy
2021-11-08	Eingeleitet	H.C. Wainwright	Buy
2021-10-28	Eingeleitet	Citigroup	Buy
2021-10-26	Eingeleitet	Cowen	Outperform
2021-10-26	Eingeleitet	Jefferies	Buy
2021-10-26	Eingeleitet	Truist	Buy

Alle ansehen

Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten

Nov 19, 2024

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution - Yahoo Finance

Nov 19, 2024

Nov 18, 2024

Principal Financial Group Inc. Trims Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 18, 2024

Nov 15, 2024

Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 14, 2024

Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR

Nov 14, 2024

Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN

Nov 13, 2024

From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English

Nov 13, 2024

The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga

Nov 13, 2024

How Vivek Ramaswamy Became A Billionaire - Forbes

Nov 13, 2024

Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News

Nov 13, 2024

Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times

Nov 13, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), Annual Income, Houses, and Cars. - Jagran Josh

Nov 13, 2024

Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0 - NDTV

Nov 13, 2024

Vivek Ramaswamy Net Worth: How this key Trump aide built his billion-dollar empire - Moneycontrol

Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new 'Department of - The Times of India

Nov 13, 2024